bibliographic resource 4706909 [br/4706909]
https://w3id.org/oc/corpus/br/4706909

is a

• document
• article

title

• Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial

publication date

• 2015-01-01

contributor

• https://w3id.org/oc/corpus/ar/18122383
• https://w3id.org/oc/corpus/ar/18122384
• https://w3id.org/oc/corpus/ar/18122385
• https://w3id.org/oc/corpus/ar/18122386
• https://w3id.org/oc/corpus/ar/18122387
• https://w3id.org/oc/corpus/ar/18122388
• https://w3id.org/oc/corpus/ar/18122389
• https://w3id.org/oc/corpus/ar/18122390
• https://w3id.org/oc/corpus/ar/18122391
• https://w3id.org/oc/corpus/ar/18122392
• https://w3id.org/oc/corpus/ar/18122393
• https://w3id.org/oc/corpus/ar/18122394
• https://w3id.org/oc/corpus/ar/18122395
• https://w3id.org/oc/corpus/ar/18122396
• https://w3id.org/oc/corpus/ar/18122397
• https://w3id.org/oc/corpus/ar/18122398
• https://w3id.org/oc/corpus/ar/18122399
• https://w3id.org/oc/corpus/ar/18122400
• https://w3id.org/oc/corpus/ar/18122401
• https://w3id.org/oc/corpus/ar/18122402
• https://w3id.org/oc/corpus/ar/18122403
• https://w3id.org/oc/corpus/ar/18122404
• https://w3id.org/oc/corpus/ar/18122405
• https://w3id.org/oc/corpus/ar/18122406
• https://w3id.org/oc/corpus/ar/18122407
• https://w3id.org/oc/corpus/ar/18122408
• https://w3id.org/oc/corpus/ar/18122409

format

• https://w3id.org/oc/corpus/re/2676068

identifier

• https://w3id.org/oc/corpus/id/9485037
• https://w3id.org/oc/corpus/id/9485038
• https://w3id.org/oc/corpus/id/9485039

part of

• https://w3id.org/oc/corpus/br/75764